In response to S&P and Moody’s maintaining Hong Kong’s AA and Aa3 credit rating respectively, the Hong Kong Special ...

In case you missed it, we saw the year’s biggest IPO kick off last week in Hong Kong. Valued at A$7.10B, it’s only fitting ...

As many as 30 Chinese companies poised for dual listings this year, co-head of global banking at UBS Securities says Hong ...

AsianFin – JD.com has joined Tencent in backing one of China's fastest-rising robotics startups, as it accelerates its foray ...

Battery giant powers the city back to global IPO top spot as finance chief highlights ties with the mainland as key to ...

The past week was a busy one for Hong Kong's IPO market, which welcomed the largest global IPO this year. Since the start of ...

Dow Jones Top Company Headlines at 11 AM ET: Booz Allen to Cut 2,500 Jobs as Business Grapples With Trump Spending Crackdown | Trump ... Booz Allen to Cut 2,500 Jobs as Business Grapples With Trump ...

Singapore biotech firm Mirxes began trading in Hong Kong on May 23 at a valuation exceeding US$1 billion. Read more at ...

In response to Fitch maintaining Hong Kong's AA- credit rating and stable outlook, the Hong Kong Special Administrative ...

In related news, Singapore-based pharmaceutical company Mirxes, which specializes in cancer treatment, also had a strong debut in Hong Kong on the same day. The company’s shares rose by 28% in morning ...

Singapore-based cancer diagnostics firm MiRXES has listed on the Hong Kong Stock Exchange, with shares jumping 24.5% above the HKD 23.3 offer price on debut. The stock was trading at HKD 30 as of 3:00 ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...